Krabbe Disease, also known as Globoid Cell Leukodystrophy
Showing 26 - 50 of >10,000
Parkinson Disease Trial in Las Vegas (Aerobic exercise)
Not yet recruiting
- Parkinson Disease
- Aerobic exercise
-
Las Vegas, NevadaUniversity of Nevada, Las Vegas
May 2, 2023
Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CIML NK
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Structural Chromosome Rearrangements and Brain Disorders
Enrolling by invitation
- Rare Diseases
- +2 more
-
Stockholm, SwedenAnna Lindstrand
Oct 2, 2023
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Neck Cancer Metastatic Trial in Baltimore (Nivolumab 480mg and
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Nivolumab 480mg and surgical resection
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Feb 25, 2022
Ankylosing Spondylitis Trial in Istanbul (home-based exercises)
Not yet recruiting
- Ankylosing Spondylitis
- home-based exercises
-
Istanbul, Bakirkoy, TurkeyBakırkoy Dr Sadı Konuk Hospıtal
Jan 19, 2023
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Recruiting
- Xeroderma Pigmentosum
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)
Recruiting
- Non-small Cell Lung Cancer
- Nutritional intervention
- Immunotherapy
-
Rotterdam, NetherlandsErasmus MC
Jun 5, 2023
Right Ventricular Function Among Chronic Lung Disease
Not yet recruiting
- Right Ventricular Function
- Echocardiographic examination
- (no location specified)
Nov 14, 2023
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- (no location specified)
Sep 13, 2023
Chinese Spondyloarthritis Inception Cohort (CESPIC)
Not yet recruiting
- Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
- +6 more
- (no location specified)
Jul 25, 2023
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New
Recruiting
- Mantle-cell Lymphoma
- B Cell Chronic Lymphocytic Leukemia
-
Monza, MB, ItalyAndrea Aroldi
May 24, 2023
Epithelial-Mesenchymal Transition Associated Markers in
Recruiting
- Peri-implantitis
-
Karbala, IraqTalib A. Alnajaty
Apr 14, 2023
Lysosomal Storage Disease, Metachromatic Leukodystrophy Trial in Milan (OTL-200)
Active, not recruiting
- Lysosomal Storage Disease
- Metachromatic Leukodystrophy
- OTL-200
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Sep 29, 2021
Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)
Completed
- Sickle Cell Disease
- Hematopoietic Stem Cell Transplantation
-
Birmingham, Alabama
- +18 more
Dec 7, 2022
Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial
Completed
- Aggressive Systemic Mastocytosis
- +3 more
-
Stanford, California
- +10 more
Jan 12, 2023
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen
Recruiting
- Recurrent Langerhans Cell Histiocytosis
- Refractory Langerhans Cell Histiocytosis
- Biospecimen Collection
- +8 more
-
Wilmington, Delaware
- +3 more
Apr 28, 2023
VO2max & HRQoL in Children With Sickle Cell Disease
Completed
- Sickle Cell
- Children
-
Montpellier, Occitanie, FrancePediatric and Congenital Cardiology Department, Arnaud De Villen
Aug 16, 2023
Inherited Metabolic Disorders Who Underwent Hematopoietic Stem
Terminated
- Inherited Metabolic Disorders (IMD)
- Safety and efficacy assessments
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 10, 2021
Plantar Fibromatosis, Ledderhose Disease Trial (EN3835, Placebo)
Not yet recruiting
- Plantar Fibromatosis
- Ledderhose Disease
- EN3835
- Placebo
- (no location specified)
Nov 21, 2023
Evaluation of Outcome Metrics in Alexander Disease
Recruiting
- Alexander Disease
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Aug 29, 2022
Respiratory Disease, Allergic Diseases and/or Mast Cell
Not yet recruiting
- Allergic Diseases
- +2 more
-
Toulouse, FranceLaurent GUILLEMINAULT
Sep 7, 2023
Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Isatuximab
- +4 more
-
Hamburg, Germany
- +3 more
Dec 16, 2022
Study of Chediak-Higashi Syndrome
Recruiting
- Chediak-Higashi Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023